XML 58 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information
9 Months Ended
Sep. 29, 2023
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in business segments consisting of the Biotechnology, Life Sciences, Diagnostics, and (prior to the Separation) Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs, including separation costs related to preparation for the separation of the Company’s Environmental & Applied Solutions business of $36 million and $101 million in the three and nine-month periods ended September 29, 2023, respectively, and other costs not considered part of management’s evaluation of reportable segment operating performance. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Segment results are shown below ($ in millions):
 Three-Month Period EndedNine-Month Period Ended
September 29, 2023September 30, 2022September 29, 2023September 30, 2022
Sales:
Biotechnology$1,664 $2,053 $5,413 $6,535 
Life Sciences1,706 1,723 5,211 5,090 
Diagnostics2,254 2,679 6,861 7,884 
Environmental & Applied Solutions1,249 1,208 3,712 3,593 
Total$6,873 $7,663 $21,197 $23,102 
Operating profit:
Biotechnology$417 $691 $1,493 $2,315 
Life Sciences313 354 974 1,022 
Diagnostics539 761 1,640 2,447 
Environmental & Applied Solutions286 286 887 829 
Other(117)(77)(333)(221)
Total$1,438 $2,015 $4,661 $6,392